Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Shares Issued (2016 - 2026)

Lexaria Bioscience's Shares Issued history spans 11 years, with the latest figure at $3.0 million for Q1 2026.

  • Quarterly results put Shares Issued at $3.0 million for Q1 2026, up 25873.16% from a year ago — trailing twelve months through Feb 2026 was $483662.0 (down 92.91% YoY), and the annual figure for FY2024 was $6.1 million, up 283.94%.
  • Shares Issued for Q1 2026 was $3.0 million at Lexaria Bioscience, down from $3.5 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $4.3 million in Q4 2024 to a low of -$6.0 million in Q3 2025.
  • The 4-year median for Shares Issued is $1.2 million (2023), against an average of $896736.1.
  • The sharpest move saw Shares Issued plummeted 419.08% in 2025, then surged 25873.16% in 2026.
  • Year by year, Shares Issued stood at $571651.0 in 2023, then soared by 660.15% to $4.3 million in 2024, then fell by 20.05% to $3.5 million in 2025, then decreased by 12.38% to $3.0 million in 2026.
  • According to Business Quant data, Shares Issued over the past three periods came in at $3.0 million, $3.5 million, and -$6.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.